This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Tiago Duarte-Silva opined on damages in a commercial arbitration between a large pharmaceutical company and a distributor.
The distributor argued lost profits due to the early termination of the agreement. His opinions centered on likely future revenues and profits from the sale of this drug in the distributor’s territory.
In the article the authors examine the April 2 Executive Order signed by President Trump highlighting US trading partners’ nontariff barriers, such as...
In this Insights piece, CRA’s Jim Burrows and Saurabh Singh, assess the trends in uranium supply, demand, and prices and examine the potential impact of...
